Serial Number
78533234
Owner
Receptor BioLogix, Inc.Attorney
Rosemary S. Tarlton and Sherri N. Blount, Barry E. Bretschneider, Thomas E. Ciotti, John F. Delaney, Stephen C. Durant, Kimberly A. Eckhart, Maame A.F. Ewusi-Mensah, Christopher E. George, Edward W. Gray, Jr., Douglas Hendricks, Lynn M. Humphreys, Gladys H. Monroy, Kate H. Murashige, Ji-Hyun Park, Carole E. Reagan, Aaron P. Rubin, Cathleen E. Stadecker, Andrew N. Spivak, Vanina Sucharitikul, Rory J. Radding, Jennifer Lee Taylor and Dean J. ZipserFiling Date
Dec 15, 2004
RBLX Trademark
Serial Number: 78533234
Trademark Classes
Owner Contact Info
3350 West Bayshore Road, Suite 150
Palo Alto, CA 94303
Entity Type: 03
Legal Representation
Attorney of Record
Rosemary S. Tarlton and Sherri N. Blount, Barry E. Bretschneider, Thomas E. Ciotti, John F. Delaney, Stephen C. Durant, Kimberly A. Eckhart, Maame A.F. Ewusi-Mensah, Christopher E. George, Edward W. Gray, Jr., Douglas Hendricks, Lynn M. Humphreys, Gladys H. Monroy, Kate H. Murashige, Ji-Hyun Park, Carole E. Reagan, Aaron P. Rubin, Cathleen E. Stadecker, Andrew N. Spivak, Vanina Sucharitikul, Rory J. Radding, Jennifer Lee Taylor and Dean J. Zipser10 trademarks filed View all →
Trademark Details
Filing Date
December 15, 2004
Registration Date
Not Registered
Published for Opposition
September 13, 2005
Goods & Services
Reagents for clinical and medical laboratory use; reagents for medical and veterinary use in connection with biological materials; pharmaceutical preparations, namely, pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of diabetes; pharmaceuticals for the treatment of insulin resistance syndrome; pharmaceuticals for the treatment of diabetes-associated vascular disease; pharmaceuticals for the treatment of neurodegenerative diseases; pharmaceuticals for the treatment of angiogenesis-related diseases; pharmaceuticals for the treatment of arthritis; pharmaceuticals for the treatment of autoimmune diseases; and pharmaceuticals for the treatment of endometriosis